Archive for the ‘china retractions’ Category
Here are the details. One article, “Chemopreventive effect of dietary glutamine on colitis-associated colon tumorigenesis in mice,” came from a group in China. Published earlier this year, the authors seem to have had some trouble with their figures. As the corrigendum explains: Read the rest of this entry »
Nearly six months after first expressing concern about the validity of a 2010 paper on multiple sclerosis, Nature Medicine has retracted the article for containing “erroneous” data — which in this case don’t seem to have existed, making them more fabricated than wrong.
The paper, “Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease,” came from a group led by Jingwu Zhang, who at the time ran GlaxoSmithKline’s Research and Development Center in Shanghai.
A group of anesthesiology researchers in China has lost their 2011 paper in Der Anaesthesist because, well, the article wasn’t theirs to begin with.
The paper, “Different anesthesia methods for laparoscopic cholecystectomy,” came from authors at the 309th Hospital of PLA, in Beijing, who purported to report on a randomized trial of 68 patients undergoing laparoscopic colon surgery with either general or spinal (that is, a nerve block) anesthesia. According to the abstract:
Read the rest of this entry »
The journal Applied Surface Science (okay, so maybe it’s not called ASS at the home office) is retracting a pair of articles in its December issue.
The first, “Structure and mechanical properties of Ni–P electrodeposited coatings,” appeared in 2009 and was written by a group of researchers in Beijing. It has been cited nine times, according to Thomson Scientific’s Web of Knowledge. Its problem: Plagiarism. According to the retraction notice: Read the rest of this entry »
The Retraction Watch archives are full of dubious distinctions — most retractions by a single researcher, longest time between publication and retraction, etc. — but now we have a competition for another: “The three most plagiarized papers.”
That new category comes to us courtesy of a retraction notice in The Scientific World Journal, “Recent Advances in DENV Receptors,” by a group of researchers in China. Here’s the new notice: Read the rest of this entry »
The authors of a recent paper in the European Journal of Preventive Cardiology on nut intake and the risk of high blood pressure and diabetes have pulled their article from publication for an undisclosed conflict of interest.
Now, you wouldn’t know this unless you were willing to pony up the $32 to read the notice, which is behind a pay wall — something that drives us, well, nuts. But here it is:
It really isn’t fair to pick on Pattern Recognition Letters, but, well, if the shoe fits…
We had fun at the expense of the journal the last time we found that a duplicate publication had escaped the editors. This time, plagiarism is to blame.
A group of authors from the Institute of Automation at the Chinese Academy of Sciences published, then promptly lost, their September 2013 article in PRL titled “Model-based 3D tracking of an articulated hand from single depth images.”
If you click on this version of “Application of the CRISPR–Cas System for Efficient Genome Engineering in Plants” (subscription required), you see this:
This paper has been withdrawn pending a decision by the Editorial Board